ASTROTECH Corp Current Income Tax Expense (Benefit)
ASTROTECH Corp (ASTC) reported Current Income Tax Expense (Benefit) of $2.00 thousand for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2025-09-26
- ASTROTECH Corp current income tax expense (benefit) for fiscal 2025 was $2.00K, a 0.00% change from fiscal 2024.
- ASTROTECH Corp current income tax expense (benefit) for fiscal 2024 was $2.00K.
- ASTROTECH Corp current income tax expense (benefit) for fiscal 2023 was $0.00.
- ASTROTECH Corp current income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-06-30 | $2.00K 10-K · filed 2025-09-26 | |
| 2024-06-30 | $2.00K 10-K · filed 2025-09-26 | |
| 2023-06-30 | $0.00 10-K · filed 2024-09-20 | |
| 2022-06-30 | $0.00 10-K · filed 2022-09-15 | |
| 2021-06-30 | $0.00 10-K · filed 2022-09-15 | |
| 2016-06-30 | -$25.00K 10-K · filed 2016-09-29 | |
| 2015-06-30 | -$5.94M 10-K · filed 2016-09-29 | |
| 2014-06-30 | -$4.15M 10-K · filed 2015-09-22 | $6.00K 10-K · filed 2014-09-30 |
| 2013-06-30 | $0.00 10-K · filed 2013-10-15 | |
| 2012-06-30 | $17.00K 10-K · filed 2013-10-15 | |
| 2011-06-30 | -$53.00K 10-K · filed 2012-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |